| 1 |
Khalil A, Sotiriadis A, Chaoui R, et al. ISUOG Practice Guidelines: role of ultrasound in congenital infection [J]. Ultrasound Obstet Gynecol, 2020, 56(1): 128-151.
|
| 2 |
Robert-Gangneux F, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis [J]. Clin Microbiol Rev, 2012, 25(2): 264-296.
|
| 3 |
Lappalainen M, Koskela P, Koskiniemi M, et al. Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG [J]. J Infect Dis, 1993, 167(3): 691-697.
|
| 4 |
朱宇宁, 尚世强, 陈英虎, 等. TORCH实验室规范化检测与临床应用专家共识 [J].中华检验医学杂志, 2020, 43(5): 553-561.
|
| 5 |
Isaac BM, Zucker JR, Giancotti FR, et al. Rubella surveillance and diagnostic testing among a low-prevalence population, New York City, 2012-2013 [J]. Clin Vaccine Immunol, 2017, 24(9): e00102-e00117.
|
| 6 |
Guerra B, Simonazzi G, Puccetti C, et al. Ultrasound prediction of symptomatic congenital cytomegalovirus infection [J]. Am J Obstet Gynecol, 2008, 198(4): 380.e1-77.
|
| 7 |
Lamont RF, Sobel JD, Vaisbuch E, et al. Parvovirus B19 infection in human pregnancy [J]. BJOG, 2011, 118(2): 175-186.
|
| 8 |
de Jong EP, Walther FJ, Kroes AC, et al. Parvovirus B19 infection in pregnancy: new insights and management [J]. Prenat Diagn, 2011, 31(5): 419-425.
|
| 9 |
Bredl S, Plentz A, Wenzel JJ, et al. False-negative serology in patients with acute parvovirus B19 infection [J]. J Clin Virol, 2011, 51(2): 115-120.
|
| 10 |
Grangeot-Keros L, Mayaux MJ, Lebon P, et al. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women [J]. J Infect Dis, 1997, 175(4): 944-946.
|
| 11 |
Vauloup-Fellous C, Grangeot-Keros L. Humoral immune response after primary rubella virus infection and after vaccination [J]. Clin Vaccine Immunol, 2007, 14(5): 644-647.
|
| 12 |
Lefevre-Pettazzoni M, Bissery A, Wallon M, et al. Impact of spiramycin treatment and gestational age on maturation of Toxoplasma gondii immunoglobulin G avidity in pregnant women [J]. Clin Vaccine Immunol, 2007, 14(3): 239-243.
|
| 13 |
Liesenfeld O, Press C, Montoya JG, et al. False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the platelia Toxo IgM test [J]. J Clin Microbiol, 1997, 35(1): 174-178.
|
| 14 |
Pastuszak AL, Levy M, Schick B, et al. Outcome after maternal varicella infection in the first 20 weeks of pregnancy [J]. N Engl J Med, 1994, 330(13): 901-905.
|
| 15 |
Liesnard C, Donner C, Brancart F, et al. Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk [J]. Obstet Gynecol, 2000, 95(6 Pt 1): 881-888.
|
| 16 |
Pass RF, Fowler KB, Boppana SB, et al. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome [J]. J Clin Virol, 2006, 35(2): 216-220.
|
| 17 |
Enders G, Daiminger A, Bäder U, et al. Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age [J]. J Clin Virol, 2011, 52(3): 244-246.
|
| 18 |
SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group, Thiébaut R, Leproust S, et al. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data [J]. Lancet, 2007, 369(9556): 115-122.
|
| 19 |
Morgan-Capner P, Miller E, Vurdien JE, et al. Outcome of pregnancy after maternal reinfection with rubella [J]. CDR (Lond Engl Rev), 1991, 1(6): R57-R59.
|
| 20 |
Puccetti C, Contoli M, Bonvicini F, et al. Parvovirus B19 in pregnancy: possible consequences of vertical transmission [J]. Prenat Diagn, 2012, 32(9): 897-902.
|
| 21 |
Morgan-Capner P, Crowcroft NS, PHLS Joint Working Party of the Advisory Committees of Virology and Vaccines and Immunisation. Guidelines on the management of, and exposure to, rash illness in pregnancy (including consideration of relevant antibody screening programmes in pregnancy) [J]. Commun Dis Public Health, 2002, 5(1): 59-71.
|
| 22 |
Enders G, Miller E, Cradock-Watson J, et al. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases [J]. Lancet, 1994, 343(8912): 1548-1551.
|
| 23 |
Fowler KB, Stagno S, Pass RF, et al. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status [J]. N Engl J Med, 1992, 326(10): 663-667.
|
| 24 |
Picone O, Vauloup-Fellous C, Cordier AG, et al. A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome [J]. Prenat Diagn, 2013, 33(8): 751-758.
|
| 25 |
Wallon M, Franck J, Thulliez P, et al. Accuracy of real-time polymerase chain reaction for Toxoplasma gondii in amniotic fluid [J]. Obstet Gynecol, 2010, 115(4): 727-733.
|
| 26 |
Tang JW, Aarons E, Hesketh LM, et al. Prenatal diagnosis of congenital rubella infection in the second trimester of pregnancy [J]. Prenat Diagn, 2003, 23(6): 509-512.
|
| 27 |
Mouly F, Mirlesse V, Méritet JF, et al. Prenatal diagnosis of fetal varicella-zoster virus infection with polymerase chain reaction of amniotic fluid in 107 cases [J]. Am J Obstet Gynecol, 1997, 177(4): 894-898.
|
| 28 |
Malinger G, Lev D, Lerman-Sagie T. Imaging of fetal cytomegalovirus infection [J]. Fetal Diagn Ther, 2011, 29(2): 117-126.
|
| 29 |
Meyberg-Solomayer GC, Fehm T, Muller-Hansen I, et al. Prenatal ultrasound diagnosis, follow-up, and outcome of congenital varicella syndrome [J]. Fetal Diagn Ther, 2006, 21(3): 296-301.
|
| 30 |
Mattson SN, Jones KL, Gramling LJ, et al. Neurodevelopmental follow-up of children of women infected with varicella during pregnancy: a prospective study [J]. Pediatr Infect Dis J, 2003, 22(9): 819-823.
|
| 31 |
Malinger G, Werner H, Rodriguez Leonel JC, et al. Prenatal brain imaging in congenital toxoplasmosis [J]. Prenat Diagn, 2011, 31(9): 881-886.
|
| 32 |
Dhombres F, Friszer S, Maurice P, et al. Prognosis of fetal parenchymal cerebral lesions without ventriculomegaly in congenital toxoplasmosis infection [J]. Fetal Diagn Ther, 2017, 41(1): 8-14.
|
| 33 |
Enders G, Bäder U, Lindemann L, et al. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome [J]. Prenat Diagn, 2001, 21(5): 362-377.
|
| 34 |
Farkas N, Hoffmann C, Ben-Sira L, et al. Does normal fetal brain ultrasound predict normal neurodevelopmental outcome in congenital cytomegalovirus infection? [J]. Prenat Diagn, 2011, 31(4): 360-366.
|
| 35 |
韩瑾, 曾斯慧, 甄理, 等. 胎儿颅内出血超声联合磁共振成像诊断与妊娠结局 [J/CD]. 中华医学超声杂志(电子版), 2015, 12(5): 383-389.
|
| 36 |
Jacquemard F, Yamamoto M, Costa JM, et al. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection [J]. BJOG, 2007, 114(9): 1113-1121.
|
| 37 |
Leruez-Ville M, Ghout I, Bussières L, et al. In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase Ⅱ study [J]. Am J Obstet Gynecol, 2016, 215(4): 462.e1-462.e10.
|
| 38 |
Kagan KO, Enders M, Schampera MS, et al. Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration [J]. Ultrasound Obstet Gynecol, 2019, 53(3): 383-389.
|
| 39 |
Revello MG, Lazzarotto T, Guerra B, et al. A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus [J]. N Engl J Med, 2014, 370(14): 1316-1326.
|
| 40 |
Congenital cytomegalovirus infection: update on treatment: scientific impact paper No. 56 [J]. BJOG, 2018, 125(1): e1-e11.
|
| 41 |
Korndewal MJ, Oudesluys-Murphy AM, Kroes ACM, et al. Long-term impairment attributable to congenital cytomegalovirus infection: a retrospective cohort study [J]. Dev Med Child Neurol, 2017, 59(12): 1261-1268.
|
| 42 |
Wallon M, Garweg JG, Abrahamowicz M, et al. Ophthalmic outcomes of congenital toxoplasmosis followed until adolescence [J]. Pediatrics, 2014, 133(3): e601-e608.
|
| 43 |
Stray-Pedersen B. Toxoplasmosis in pregnancy [J]. Baillieres Clin Obstet Gynaecol, 1993, 7(1): 107-137.
|
| 44 |
Paquet C, Yudin MH. No. 285-Toxoplasmosis in pregnancy: prevention, screening, and treatment [J]. J Obstet Gynaecol Can, 2018, 40(8): e687-e693.
|
| 45 |
American College of Obstetricians and Gynecologists. Practice bulletin no. 151: Cytomegalovirus, parvovirus B19, varicella zoster, and toxoplasmosis in pregnancy [J]. Obstet Gynecol, 2015, 125(6): 1510-1525.
|
| 46 |
郭家菊, 秦越, 李胜利. 胎儿先天性白内障产前超声诊断及研究分析 [J/OL]. 中华医学超声杂志(电子版), 2021, 18(3): 285-289.
|
| 47 |
Nagel HT, de Haan TR, Vandenbussche FP, et al. Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection [J]. Obstet Gynecol, 2007, 109(1): 42-47.
|
| 48 |
Fairley CK, Smoleniec JS, Caul OE, et al. Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection [J]. Lancet, 1995, 346(8986): 1335-1337.
|
| 49 |
American Academy of Pediatrics Committee on Infectious Diseases: the use of oral acyclovir in otherwise healthy children with varicella [J]. Pediatrics, 1993, 91(3): 674-676.
|
| 50 |
Miller E, Cradock-Watson JE, Ridehalgh MK. Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus [J]. Lancet, 1989, 2(8659): 371-373.
|